The Spaulding Rehabilitation Hospital Corporation

The Spaulding Rehabilitation Hospital Corporation, a tax-exempt non-profit hospital based in Charlestown, Massachusetts, acts as a federal grant recipient conducting neurological and musculoskeletal rehabilitation research and development for civilian health agencies, with 56% of recent awards held as prime recipient and 44% as sub-recipient on federally funded projects.

Spaulding's federal footprint is entirely grant-funded research and development work. The organization serves as recipient on project grants, block grants, cooperative agreements, and career development awards (K23, F32, K01 mechanisms) across the National Institutes of Health (NIH) and Defense Health Agency (DHA), with research focused on spinal cord injury rehabilitation, traumatic brain injury recovery, chronic pain management, osteoarthritis mechanisms, and integrative medicine therapies. Representative prime grant work includes a $1.97 million National Institute on Aging project grant awarded August 2025 investigating network medicine-based therapeutics for knee osteoarthritis using exercise and nutritional interventions in aged murine models; a $3.94 million Military Medical Research and Development project grant from the Army Medical Command (CFDA 12.420) awarded September 2022 supporting the BO2ST clinical trial testing acute intermittent hypoxia combined with transcutaneous spinal stimulation for chronic spinal cord injury; a $777,538 DHA project grant awarded November 2025 for the WALK DOC research initiative using robotic exoskeleton technology to improve behavioral responsiveness in patients with disorders of consciousness; and a $249,479 Administration for Community Living (ACL) National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR, CFDA 93.433) project grant awarded September 2025 supporting disability research with a sub-award component to The University of Texas Southwestern Medical Center. Spaulding also holds a $250,000 NIDILRR block grant (CFDA 93.433) awarded September 2025 for translating diabetes prevention evidence-based research into practice for people with acquired brain injury, with Baylor Research Institute as sub-awardee.

Customer concentration is heavily weighted to health and rehabilitation research agencies within HHS. The top five funding agencies by award count account for 59% of all awards: the National Institute on Aging (14 awards), the Administration for Community Living (13 awards), the National Center for Complementary and Integrative Health (8 awards), the National Institute of Neurological Disorders and Stroke (7 awards), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (6 awards). The combined dollars obligated across all 81 awards—$126.7 million—far exceed the combined potential value ($1.6 million) on the books, signaling that the portfolio reflects realized, completed, and ongoing funded research activity rather than future opportunity.

Activity peaked in 2024 at 19 awards, with 18 awards in 2025 and 2 awards in the first five months of 2026. Seventeen awards face ultimate completion within the next twenty-four months, creating recompete opportunity. Spaulding acts as sub-recipient on multiple collaborative projects with prime grantees including the University of Pittsburgh, The Ohio State University, Indiana University, Boston University, Harvard University (the General Hospital Corporation and President and Fellows of Harvard College), the University of Massachusetts, and the University of Alabama at Birmingham, covering research in traumatic brain injury rehabilitation, repetitive head impact characterization, voice analysis for Parkinson's disease detection, comparative rehabilitation approaches, and specialized equipment and technology research networks. The organization's capability posture centers on clinical research delivery, specialized rehabilitation outcome assessment, patient recruitment and enrollment, and contribution to research infrastructure and data standardization—with particular strength in disorders of consciousness, spinal cord injury recovery trajectories, pain neurobiology, and aging-related musculoskeletal and neurological conditions.